Prieto J, Qian C, Garcia N, Diez J, Medina JF
C th chng ta mi ngy u tip xc vi nhng tc nhn gy oxy ha c th
For now, there is no strong evidence that prescribing semaglutide needs to change in our practice. Associate Professor Simonis says all patients on weight-lowering medications should still be reviewed monthly regarding their response and that is an opportunity to discuss other issues
NITs: non-invasive tests
[5] [17] Symptoms of hypoglycemiaincluding confusion, excessive sweating, tremor, rapid heartbeat, or loss of consciousnessrequire immediate intervention, especially in patients taking concurrent insulin or sulfonylureas
Transient receptor potential ankyrin 1 (Trpa1) mediates lipopolysaccharide (Lps)-induced inflammatory responses in primary human osteoarthritic fibroblast-like synoviocytes